Genome Medical INC.

A nationwide network of clinical genetics experts and genomic care delivery platform.

Based in DC

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $25K in lobbying spend across 4 quarterly filings, Genome Medical INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2019 to 2020.

$25K
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2019$8K
2020$17K

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

Ipolicy Solutions

Lobbyists

Jennifer LeibMegan Anderson Brooks

Government Agencies Targeted

These are the government entities that Genome Medical INC. disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

Payment and service delivery models.

Coverage for genetic counseling services

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

America's Health Insurance Plans INC (Ahip)
$96.4M total spend
U S Chamber Institute for Legal Reform
$58.7M total spend
GSK (FKA Glaxosmithkline INC.)
$39.9M total spend
National Association of Children's Hospitals (N.a.c.h.)
$38.0M total spend
Walgreen Company
$24.4M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.